- Home
- SUPN vs INSW Comparison
SUPN vs INSW Comparison
Compare SUPN & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- INSW
- Stock Information
- Founded
- SUPN 2005
- INSW 1999
- Country
- SUPN United States
- INSW United States
- Employees
- SUPN N/A
- INSW N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- INSW Semiconductors
- Sector
- SUPN Health Care
- INSW Technology
- Exchange
- SUPN Nasdaq
- INSW Nasdaq
- Market Cap
- SUPN 1.9B
- INSW 1.7B
- IPO Year
- SUPN 2012
- INSW N/A
- Fundamental
- Price
- SUPN $32.28
- INSW $40.16
- Analyst Decision
- SUPN Hold
- INSW Buy
- Analyst Count
- SUPN 2
- INSW 2
- Target Price
- SUPN $36.00
- INSW $52.00
- AVG Volume (30 Days)
- SUPN 529.3K
- INSW 615.4K
- Earning Date
- SUPN 08-05-2025
- INSW 08-06-2025
- Dividend Yield
- SUPN N/A
- INSW 9.98%
- EPS Growth
- SUPN N/A
- INSW N/A
- EPS
- SUPN 1.11
- INSW 6.47
- Revenue
- SUPN $667,997,000.00
- INSW $860,606,000.00
- Revenue This Year
- SUPN N/A
- INSW N/A
- Revenue Next Year
- SUPN $12.02
- INSW $2.05
- P/E Ratio
- SUPN $29.32
- INSW $6.19
- Revenue Growth
- SUPN 11.82
- INSW N/A
- 52 Week Low
- SUPN $25.55
- INSW $27.20
- 52 Week High
- SUPN $40.28
- INSW $60.99
- Technical
- Relative Strength Index (RSI)
- SUPN 48.28
- INSW 61.58
- Support Level
- SUPN $31.56
- INSW $38.11
- Resistance Level
- SUPN $33.15
- INSW $41.17
- Average True Range (ATR)
- SUPN 0.92
- INSW 1.30
- MACD
- SUPN -0.03
- INSW 0.24
- Stochastic Oscillator
- SUPN 40.34
- INSW 81.87
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.